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Longitudinal genetic analyses of Staphylococcus
aureus nasal carriage dynamics in a diverse
population
Gowrishankar Muthukrishnan1, Ryan P Lamers1,2, Austin Ellis1, Vanathy Paramanandam1, Alana B Persaud1,
Sergio Tafur3, Christopher L Parkinson4 and Alexander M Cole1*
Abstract
Background: Staphylococcus aureus (SA) nasal colonization plays a critical role in the pathogenesis of
staphylococcal infections and SA eradication from the nares has proven to be effective in reducing endogenous
infections. To understand SA nasal colonization and its relation with consequent disease, assessment of nasal
carriage dynamics and genotypic diversity among a diverse population is a necessity.
Results: We have performed extensive longitudinal monitoring of SA nasal carriage isolates in 109 healthy
individuals over a period of up to three years. Longitudinal sampling revealed that 24% of the individuals were
persistent SA nasal carriers while 32% were intermittent. To assess the genetic relatedness between different SA
isolates within our cohort, multi locus sequence typing (MLST) was performed. MLST revealed that not only were
strains colonizing intermittent and persistent nasal carriers genetically similar, belonging to the same clonal
complexes, but strain changes within the same host were also observed over time for both types of carriers. More
highly discriminating genetic analyses using the hypervariable regions of staphylococcal protein A and clumping
factor B virulence genes revealed no preferential colonization of specific SA strains in persistent or intermittent
carriers. Moreover, we observed that a subset of persistent and intermittent carriers retained clinically relevant
community-acquired methicillin-resistant SA (CA-MRSA) strains in their nares over time.
Conclusions: The findings of this study provides added perspective on the nasal carriage dynamics between strains
colonizing persistent and intermittent carriers; an area currently in need of assessment given that persistent carriers
are at greater risk of autoinfection than intermittent carriers.
Keywords: Staphylococcus aureus, Bacterial genetics, Multi locus sequence typing, Nasal colonization, spa typing,
MRSA, SCCmec typing
Background
Staphylococcus aureus (SA) is a leading cause of
community-acquired and nosocomial bacterial infections
in humans. SA infections can range from mild skin
infections to severe, highly invasive and necrotizing
diseases [1]. With the spread of community-acquired
methicillin-resistant SA (CA-MRSA) and vancomycin-
resistant SA (VRSA) strains around the world, it has
become even more pertinent to conduct SA epidemio-
logical studies to monitor its dissemination [2,3].
The most common niche of SA in humans is the an-
terior nares [4-6] and SA nasal colonization is thought
to be a major source of bacterial transmission with SA
colonizing approximately 25% of the human population
asymptomatically [7-9]. Staphylococcus aureus nasal
colonization has been attributed to an amenable host, and
numerous epidemiological studies have been conducted to
identify nasal carriers and non-carriers of SA [9-11]. How-
ever, to understand better the dynamics of SA nasal car-
riage over time, longitudinal studies are required. Nasal
carriage patterns amongst healthy individuals can be
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broadly classified as persistent (always colonized by SA in
their nares), intermittent or non-carriers [9,12,13]. This
distinction is important as persistent carriers are at a
higher risk of developing active auto-infections than inter-
mittent and non-carriers [9,11,14,15].
To understand better the genetic diversity of SA
strains that colonize nasal carriers, the population struc-
ture of SA strains obtained from healthy individuals
must be defined and detailed. Multi locus sequence typ-
ing (MLST) is one of the most common means by which
population structure of SA strains have been analyzed
[16-18]. More recently, genotyping of hypervariable viru-
lence genes (staphylococcal protein A (spa) [19,20] and
clumping factor B (clfB) [21]) have also been employed
to enhance strain resolution and thus offer better
characterization of genetic relatedness between SA
strains. Moreover, with the increasing prevalence of CA-
MRSA, it is critical to understand the origin and the dis-
semination of major MRSA clones within the healthy
population [22-25]. SCCmec typing, the most common
means by which to identify MRSA, has become a vital
tool for the characterization of CA-MRSA clones in epi-
demiological studies [26,27].
Several studies including ours [28,29] have shown that
SA nasal colonization is multifactorial, involving not
only bacterial determinants but also host factors that
predispose individuals to SA carriage [7,30-35]. However,
the exact mechanisms leading to persistent versus intermit-
tent or non-carriage remain unclear. It is also unknown
whether persistent and intermittent hosts preferentially
carry a specific genotype of SA strains. Therefore, under-
standing the patterns of nasal carriage and the preferential
colonization by certain genotypes of SA strains in persist-
ent and intermittent carriers will greatly augment our un-
derstanding of SA nasal carriage.
Recently, we revealed genetic associations between
nasal carriage strains and clinical isolates in a cross-
sectional survey of healthy individuals [36]. In the
current study, we extended these analyses and longitu-
dinally assessed the population structure of SA nasal car-
riage strains in a diverse population for a period of up to
three years to gain a better understanding of nasal
carriage dynamics, in addition to assessing whether pref-
erential colonization by certain genotypic SA strains
occurs within persistent versus intermittent carriers.
Interestingly, MLST analyses revealed that both intermit-
tent and persistent carriers harbor genotypically similar
strains that cluster into the same clonal complexes. Fur-
thermore, these strains exhibited similarity to SA isolates
of clinical significance. Genotyping studies using house-
keeping (MLST) and hypervariable virulence genes (spa
and clfB) revealed that both persistent and intermittent
carriers change strains over time with no difference in
the frequency of strain change between the two carrier
groups. The current study contrasts previous findings
that have indicated that persistent carriers carry the
same SA strain over long periods of time while intermit-
tent carriers carry different strains during SA nasal car-
riage [9,37]. Overall, this study indicates that colonizing
strains of SA are not specific to a particular host or
carriage type (i.e., persistent versus intermittent car-
riers) and both carriage type change strains over time,
suggesting that other non-SA factors could be contrib-
uting to specific carriage states.
Methods
Ethics statement for collection of bacterial strains from
donors
The current study was approved by the University of
Central Florida’s Institutional Review Board (UCF IRB).
All donors provided informed written consent to partici-
pate in the current study. Nasal swab sample collection
for the current study was undertaken in the University
of Central Florida (UCF) campus. UCF is a diverse com-
munity of nearly 60,000 students and approximately
8000 faculty and staff members of various ages, ethnic
and racial backgrounds. All procedures and investigators
involved in the sample collection process were Institu-
tional Review Board (IRB)-approved with Collaborative
Institutional Training Initiative (CITI) certification.
Study population, design and bacterial strains
A total of 329 healthy individuals at UCF were screened
for the presence of SA in their anterior nares. Specifically,
the donor population (58.35% - Female, 40.72% - Male and
0.93% - Unreported) consisted of participants from various
racial and ethnic backgrounds (White −56.84%, Asian –
13.07%, Black – 17.63%, Pacific Islanders – 1.22%, His-
panic/Latino – 13.07%). Of the 329 individuals screened,
96 (29.2%) tested positive for SA nasal colonization at least
once while the remaining 233 (70.8%) donors were classi-
fied as non-carriers because SA was never isolated from
their nares. Of the 329 total individuals enrolled in our
study, 109 participants – comprised of 61 carriers and 48
non-carriers – were monitored longitudinally (i.e., multiple
nasal swab samples were collected from these individuals).
Among the 96 SA positive carriers, 61 were monitored lon-
gitudinally while the remaining 35 carriers were screened
for nasal colonization only once. In total, a median of four
(range 2–18) nasal samples were obtained from each of
109 healthy individuals (including individuals that tested
negative for SA) for a varying period of up to three years,
with duration and frequency of collections dependent on
donor availability. Following screening, donors were classi-
fied into persistent (if all nasal cultures tested SA positive
for the duration of the study), intermittent (if at least one
nasal culture tested negative for SA over the course of the
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study), and non-carriers (no cultures tested positive for SA)
of SA.
Following nasal sample collection, SA strains were iso-
lated as previously described [36]. Briefly, the anterior
nares of the donors were swabbed with sterile, unflocked
polyester-tipped swabs (Fisher Scientific, Pittsburgh,
Pennsylvania, USA) and nasal samples were grown
overnight on nutrient rich Tryptic Soy Agar (TSA)
supplemented with 5% sheep’s blood (Becton, Dickinson
and Company, Franklin Lakes, New Jersey, USA). Bac-
terial colonies were identified as SA using Staphyloslide™
Latex Test reagent (Becton, Dickinson and Company,
Franklin Lakes, New Jersey, USA) and sub-cultured in
Trypticase Soy Broth (TSB; Becton, Dickinson and
Company, Franklin Lakes, New Jersey, USA) overnight
at 37°C and 250 rpm. Overnight cultures were subse-
quently used for isolation of genomic DNA.
Multi locus sequence typing
Genomic DNA from SA isolates was extracted using
GenElute™ Bacterial Genomic DNA kit (Sigma-Aldrich
Co., St. Louis, Missouri, USA), according to the manu-
facturer’s instructions. Following extraction, multi locus
sequence typing (MLST) of seven housekeeping genes
(arcC, aroE, glpF, gmk, pta, tpi, and yqiL) was performed
using primers and PCR conditions as previously de-
scribed [17,36]. Sequence types (STs) for each SA strain
were obtained based on the alleles identified at each of
the seven loci using the SA MLST database (http://
www.mlst.net). New alleles and STs were submitted to
the MLST database curator and subsequently added to
the database.
Phylogenetic analyses of MLST data
Phylogenetic analysis of the concatenated MLST data of
all isolates was performed as previously described [36]
using the Metropolis-Hastings coupled Markov chain
Monte Carlo method (MCMC) implemented in MrBayes
v3.1.2 [38-40]. Triplicate MCMC analyses were performed
in parallel [40] using the STOKES IBM High Performance
Computing Cluster at UCF. Bayesian MCMC analyses
were carried out using both partitioned and unpartitioned
concatenated MLST data. Best-fit evolutionary models for
each individual gene fragment (in the partitioned dataset)
as well as unpartitioned dataset were selected based on
Akaike Information Criterion implemented in jModelTest
v0.1.1 [38,41]. For the concatenated unpartitioned MLST
dataset, a generalized time-reversible (GTR) evolutionary
model with inverse-gamma distribution was selected as
the best-fit model. For loci glpF, pta and yqiL in the
partitioned dataset, the Hasegawa, Kishino and Yano
(HKY) substitution model was chosen while a HKY model
with a gamma distribution was chosen for the arcC gene
[42]. Additionally, the HKY model including invariable
sites (HKY + I) was selected for locus gmk. For the tpi
locus, a GTR substitution was the chosen model while a
GTR + I model was identified as the best-fit substitution
model for the aroE locus. Within each replicate MCMC
analysis two independent Bayesian runs were performed
with random starting trees and default settings. Each run
consisted of 5 million generations with every 100 steps be-
ing sampled. For each analysis, a steady stationary state of
the run was verified using Tracer v1.5 and a burn-in of
25% of the generations was performed. A final run
consisting of 20 million generations was also performed to
verify the likelihood scores from the shorter runs were
consistent with the longer runs.
eBURST analyses of MLST data
The different Sequence types (STs) that were identified
for each SA strain were classified into different groups
using the eBURST v3 analysis software [43,44]. Each ST
was assigned to a cluster group requiring six of the
seven loci between members of the group to be identical
[44]. eBURST analysis was also used to assess relatedness
of nasal carriage strains to nosocomial epidemic strains.
spa typing and eBURP
SA isolates were spa genotyped using primers and PCR
conditions described previously [19,20] and sanger se-
quenced [45] at Eton Bioscience Inc. DNA sequencing
facility (Durham, North Carolina, USA). spa types were
determined using the Ridom StaphType (Ridom GmbH)
software (http://www.spaserver.ridom.de/). All spa types
including those newly identified were synchronized with
the global spa type database via the StaphType server.
To partition the intermittent and persistent carriers,
eBURP-clustering analysis using the Ridom StaphType
software was performed using default settings. SA iso-
lates having less than 5 repeat units were excluded from
the clustering analysis, as it is difficult to infer evolution-
ary history of a SA strain from spa type with less than
five repeat units [20].
clfB typing and sequence
For all SA isolates, the hypervariable region of the clfB
gene was amplified and sequenced using the protocols
and primers described previously [46,36]. Subsequently,
sequence analyses of the hypervariable repeat region
was performed using the in-house sequence analysis
software described previously [36]. Briefly, the nucleo-
tide sequence of the R region of clfB gene was converted
into a numeric profile based on the unique repeat units
(Additional file 1: Table S3). Subsequently, each unique
repeat unit was assigned a specific color-coded box and
the numeric output profile of clfB R region was converted
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into a color-coded representation (Additional file 2: Figure
S3) [36].
SCCmec typing
SA isolates were also screened for the presence of the
SCCmec gene cassette that confers resistance to the anti-
biotic methicillin. Phenotypic screens for MRSA strains
were performed by streaking single SA colonies on se-
lective chromogenic MRSASelect™ agar plates (Bio-Rad,
Hercules, CA, USA) and identified following the manu-
facturer’s instructions. Following the phenotypic screen-
ing, a multiplex PCR reaction amplifying eight different
loci of the SCCmec gene cassette was performed on the
MRSA strains to determine the type assignment of the
mec gene. The primers, protocols, and analyses used for
multiplex PCR were performed as previously described
[26,27].
Statistical analysis
Student’s t-tests for the differences in the length of clfB
R region and X domain repeat region of spa gene were
conducted using GraphPad Prism 4 software (GraphPad
Software, La Jolla, CA, USA). A 2 × 2 contingency table
was constructed and a G-test was performed to analyze
the distribution of persistent and intermittent carriers
among males and females within the cohort. Similarly, a
2 × 2 contingency table was constructed to evaluate the
trend of SA strain change between persistent and inter-
mittent carriers and a G-test was performed to assess
the differences in strain change in persistent and inter-
mittent carriers. G-tests were performed using JMP Pro
software (SAS Institute Inc., Cary, NC, USA) [47].
Results
Longitudinal assessment of SA nasal colonization in a
healthy population identified persistent and intermittent
carriers
To assess nasal colonization state over time, extensive
longitudinal monitoring was performed in which mul-
tiple nasal samples were obtained from 109 healthy indi-
viduals for a period of up to three years. Following
longitudinal sampling, donors were classified into per-
sistent, intermittent, and non-carriers of SA based on
their carrier indices (defined as the number of SA posi-
tive nasal swabs over the total number of swabs for each
individual; Figure 1) such that all non-carriers and
persistent carriers have carrier indices of exactly 0 and 1
respectively, while intermittent carriers have scores be-
tween 0 and 1. In total, sixty-one (56%) individuals were
SA nasal carriers (23.8% persistent and 32.1% intermit-
tent) and 48 (44.0%) were non-carriers. Within the study
population, 23.8% of all female donors were persistent
carriers while 30.1% were intermittent and 23.9% of all
male participants were persistent carriers while 34.7%
were intermittent (Likelihood ratio χ2 = 0.070, N = 61,
degrees of freedom (df =1), p = 0.7911, Table 1). Our
comprehensive longitudinal monitoring for SA nasal
colonization revealed true persistent and intermittent
carriers and subsequently, genotyping studies were con-
ducted on the isolated SA strains to assess genetic re-
latedness among them.
SA strains isolated from persistent and intermittent
carriers belong to the same genetic clusters as
nosocomial strains
We have recently revealed genetic associations between
nasal carriage strains and clinical isolates [36]; however,
this initial study was a static cross-sectional survey that
did not account for the nasal carrier class of donors (i.e.
persistent vs. intermittent). In the current study, we have
extended these analyses to a larger cohort of donors, in-
cluding persistent and intermittent carrier strains that
were monitored longitudinally for a period of up to three
years. To determine the genetic relatedness among SA
Figure 1 Distribution of SA nasal carrier indices among 109
healthy individuals monitored longitudinally. Carrier index is
defined as the number of SA positive nasal swabs over number of
total swabs for each individual person. A total of 61 SA nasal carriers
and 48 non-carriers were monitored longitudinally and their
respective carrier indices are represented here. NC, indicates SA non-
carrier state; SA intermittent carriage state; and PC, SA persistent
carriage state.
Table 1 Distribution of persistent and intermittent
carriers among males and females
Sex Carriers (% carriage distribution across sex)# Totala
Persistent Intermittent Non-carriers
Male 11 (23.9) 16 (34.7) 19 (41.4) 46
Female 15 (23.8) 19 (30.1) 29 (46.1) 63
Totalb 26 35 48 109
#Only nasal swabs from carriers sampled 2 or more times were only included.
aTotal number of nasal carriers distributed across each sex.
bTotal number persistent, intermittent and non-carriers monitored during
the study.
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strains, MLST analyses were performed on 297 SA nasal
carriage strains obtained from 96 individuals. A total of
42 different sequence types (STs) were observed with 10
being newly identified (refer to Additional file 1: Table
S1 for genotyping details of all SA strains used in this
study). Three novel alleles were also identified in this
study at loci glpF, gmk and pta. Sequence types 5 (21.3%
of all carriers), 30 (18% of all carriers) and 8 (16.4% of
all carriers) were the most prevalent STs observed within
the cohort (Table 2). Staphylococcus aureus strains be-
longing to ST15 were only isolated from persistent car-
riers. However, only one of these persistent carriers was
monitored for more than one year and as such, elaborate
longitudinal monitoring of a larger cohort of donors
containing ST15 SA strains is required to determine if
there is any preferential colonization of persistent car-
riers by ST15 SA strains.
Bayesian MCMC analysis of the concatenated MLST
data revealed that SA strains isolated from persistent
and intermittent carriers are closely related. Persistent and
intermittent carriers as well as strains isolated from clin-
ical studies all group within the same clades (Figure 2A).
Since the cohort included healthy individuals that were
singly sampled (cross-sectional), phylogenetic analyses in-
corporating SA MLST data from these individuals were
also performed (Additional file 3: Figure S1, Supplemental
Information) and the analyses reveal that all SA carrier
strains within the cohort are highly similar to strains of
clinical origin.
In addition to identifying phylogenetic relationships,
eBURST clustering of the MLST data confirmed that
persistent and intermittent carrier strains belong to the
same clonal complexes as that of epidemic strains. As
observed in Figure 2B, eBURST delineated nasal carriage
and clinical strains into 10 groups and 11 singletons. Of
these, five groups contained both clinical and nasal car-
riage strains and groups identified by eBURST also
contained STs from both persistent and intermittent car-
rier strains (data not shown). Collectively, the phylogenetic
analyses revealed genetic relatedness between persistent
and intermittent carrier strains, in addition to genetic
similarities with strains isolated from clinical settings.
SA strains from the nares of both persistent and
intermittent carriers change over time
To date, few studies longitudinally assessed whether
nasal carriage strains of SA in the nares of persistent and
intermittent carriers change over time. Longitudinal
monitoring of 61 carriers (both persistent and intermit-
tent) revealed variations in the STs of SA nasal carriage
strains over time. A representative set of persistent and
intermittent carriers that were monitored between one
and three years is depicted in Figure 3, revealing the pat-
terns of strain change. In addition, 48 healthy individuals
were monitored over time and identified as true non-
carriers (see Additional file 4: Figure S2, Supplemental
Information). Notably, it was observed that individuals
who share households (such as spouses, siblings, room-
mates, etc.) tended to carry genetically similar strains
(Additional file 1: Table S2). For example, family members
and individuals living in the same households (D528-
D549, D523-D594, D618-D619 and D20-D547-D604
(Figure 3)) carried genetically similar strains at one or
more sampling times. Interestingly, we observed that
intermittent carriers D523 and D618 harbored genetically
similar strains as that of their living partners D594 and
D619, respectively. Additionally, it was observed that per-
sistent carriers D619 and D635, who are identical twins,
carried genetically similar strains during the entire study
period. Though additional correlative studies are required,
interesting trends of SA transmission over time among in-
dividuals living in the same household were observed
within the cohort.
Previous reports have indicated that a single strain of
SA colonizes the nose for long periods of time in persist-
ent carriers while strains colonizing intermittent carriers
tend to exhibit more extensive genotypic diversity [9,37].
In contrast, within our cohort, we observed that over
time, 27% of persistent carriers and 23% of intermittent
carriers changed the ST of their SA strain (Likelihood
ratio χ2 = 0.132, N = 61, df =1, p = 0.7160, Table 3). Add-
itionally, phylogenetic analyses of the MLST data re-
vealed that SA strains from these carriers clustered into
the same genetic clades exhibiting a high degree of re-
latedness. Taken together, these results indicate similar
genotypic diversities of colonizing strains in persistent
and intermittent carriers.
Table 2 Predominant STs in persistent and intermittent
carriers
Sequence
type (ST) of S.
aureus strains#
Number of donors carrying
each ST (% of donors carrying
each ST)a
Totalb
Persistent Intermittent
ST5 5 (19.2) 8 (22.8) 13 (21.3)
ST30 5 (19.2) 6 (17) 11 (18)
ST8 4 (15.4) 6 (17) 10 (16.4)
ST45 1 (3.8) 2 (5.7) 3 (4.9)
ST15 4 (15.4) 0 4 (6.5)
ST59 1 (3.8) 2 (5.7) 3 (4.9)
ST188 1 (3.8) 3 (8.5) 4 (6.5)
#Only nasal swabs from carriers sampled 2 or more times were included and
only the most prominent STs prevalent in North America are presented here.
aPercentage calculated using the total number of persistent and intermittent
carriers in the cohort.
bTotal number persistent and intermittent carriers that carried one or more
strains in their noses.
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Figure 2 SA strains from persistent and intermittent nasal carriers are genetically related to nosocomial epidemic strains. (A) Bayesian
MCMC analysis of persistent carrier strains (colored in blue), intermittent carrier strains (colored in black) and nosocomial epidemic strains
(colored in red). Numbers at each node indicate posterior probability support and grey-filled circles represent 100% posterior probability.
(B) eBURST analysis of the MLST data clusters STs from intermittent and persistent carriers into same clonal complexes and into groups that are
represented by numbers in grey. STs colored in black are nasal carrier strains, STs colored in red are epidemic strains and those in green contain
both carrier and epidemic strains. Circle sizes in each cluster are proportional to the number of isolates and blue circles are founders of that
particular cluster.
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Genotyping of hypervariable virulence genes revealed no
preferential colonization of either persistent or
intermittent carriers by specific SA strain genotypes
As MLST is based on housekeeping genes that evolve
slowly [18], we also genotyped hypervariable virulence
genes (spa and clfB) in order to obtain higher levels of
strain resolution and further characterize the relatedness
among strains obtained from persistent and intermittent
carriers. Genotyping of the virulence gene spa was
performed on 242 SA strains isolated from persistent
and intermittent carriers. A total of 41 unique spa types
were obtained, nine of which were newly identified in
this study. Interestingly, high sub-ST strain resolution
was obtained at the spa locus (discriminatory index of
0.957), and 11 (26.83%) of the 41 spa types identified
contained persistent and intermittent carrier strains
exhibiting identical X domain repeats.
eBURP-clustering analysis performed on the SA strains
grouped them into seven clonal complexes (spa-CC) and
13 singletons (refer to Additional file 1: Table S1 for spa
typing details of all SA strains used in this study). Inter-
estingly, eBURP revealed that spa types from both per-
sistent and intermittent carriers clustered into the same
clonal complexes, confirming the high degree of genetic
relatedness observed in MLST phylogenetic analyses
(Figure 4A).
In addition to spa typing, we also performed genotyp-
ing of the hypervariable R region of clfB. This region de-
termines the length of the extracellular ligand binding
domain of ClfB protein, which is thought to influence
Figure 3 Longitudinal monitoring reveals that SA strains from both persistent and intermittent nasal carriers change over time. A
representative set of persistent and intermittent carriers that have been monitored for at least one year is depicted here. (C) indicates SA nasal
carriage at the time of swabbing and (N) indicates SA non-carrier state. Colors represented in the figure correspond to different Sequence Types
(STs) identified by MLST. STs are segregated into different cluster groups by eBURST analysis. Carriers within the same household are grouped
next to each other (indicated by * and flower bracket). (NA) corresponds to ST not available.
Table 3 Persistent and Intermittent carriers carrying more
than one unique SA lineage in their noses during the
study period
Number of
different S. aureus
strains#
Carriers (% of total in the
carrier group)
Totala
Persistent Intermittent
1 19 (73) 27 (77) 46 (75.4)
2 6 (23) 4 (11.5) 10 (16.4)
3 1 (4) 3 (8.5) 4 (6.6)
4 0 0 0
5 0 1 (3) 1 (1.6)
Totalb 26 35 61
#Nasal swabs from carriers monitored 2 or more times were only included.
aPercentage calculated using the total number of persistent and intermittent
carriers in the cohort.
bTotal number persistent and intermittent carriers that carried one or more
strains in their noses.
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bacterial adherence to host epithelia [48]. A previously
developed in-house software was used to analyze this
clfB R region [36]. Nucleotide analysis of the clfB R re-
gion was performed on 244 SA strains isolated longitu-
dinally, and a total of 109 unique repeat units were
observed (Additional file 1: Table S3). Though variability
was observed in the clfB gene fragments, 34.15% of all
persistent carrier strains analyzed in our study contained
identical sequence repeats to strains isolated from inter-
mittent carriers, revealing relatedness between the SA
strains. Figure 4B depicts the sequence similarity of the
clfB repeat regions in a representative sampling of nasal
carriage strains isolated from persistent and intermittent
carriers. Refer to Additional file 2: Figure S3 for clfB typ-
ing details of all SA strains analyzed in this study.
Recently, human in vivo nasal colonization studies re-
vealed ClfB exhibits a crucial function in bacterial adher-
ence to the nares [32]. Therefore, we assessed whether
differences in the length of clfB R region would correlate
to intermittent or persistent carriage. Persistent carrier
Figure 4 Genotyping of hypervariable virulence genes revealed no preferential colonization of specific genotypes of SA strains in
persistent and intermittent carriers. (A) eBURP clustering analysis based on spa types revealed that both persistent and intermittent carrier
strains belonged to same clonal complexes. spa types colored in blue contain only persistent carriers while those in black contain only
intermittent carriers. spa types colored in green contain both intermittent and persistent carriers. Circle sizes in each cluster are proportional to
the number of isolates and inferred founders (blue circles) and sub-founders (yellow circles) of each cluster are also represented here. spa types
with less than 5 repeats were excluded from the eBURP analysis. (B) A representative set of SA persistent (colored in blue) and intermittent
(colored in black) carrier strains having indistinguishable clfB R domain repeat region sequences. Like-colored boxes indicate 100% sequence
similarity between SA strains.
Muthukrishnan et al. BMC Infectious Diseases 2013, 13:221 Page 8 of 13
http://www.biomedcentral.com/1471-2334/13/221
strains contained nearly identical R region lengths com-
pared to intermittent carrier strains (p = 0.6646, Figure 5),
suggesting that strains from these groups exhibit a high
degree of relatedness. A similar analysis of the X domain
repeat region of spa also revealed no significant differ-
ence in length between these two groups (p = 0.7797,
Figure 5).
Collectively, longitudinal monitoring of SA nasal car-
riage strains followed by MLST and genotyping of hyper-
variable virulence genes (spa and clfB) revealed a high
degree of genetic relatedness between SA strains colon-
izing persistent and intermittent carriers. These results
indicate no preferential colonization of either persistent
or intermittent carriers by certain genotypes of SA.
Persistent and intermittent carriers harbor epidemic
MRSA strains in their nares longitudinally over time
All 297 SA strains analyzed in this study were subjected
to phenotypic screening to identify MRSA strains, and
11.78% of all SA carriers (sampled once or multiple
times) carried MRSA strains in their nares. A subset of
persistent and intermittent carriers harbored strains that
were similar to CA-MRSA strains in their nares longitu-
dinally over time (Table 4). Both occurrences of losing
and acquiring MRSA strains were observed in these car-
riers throughout the colonization study period. Persist-
ent carrier D798 carried an ST8-SCCmec type IV strain,
which is genetically similar to the widely disseminated
epidemic CA-MRSA strain USA300. Additionally, the
persistent carrier D535 acquired and carried ST5-SCCmec
type II MRSA strain for over two years. This strain is ge-
notypically similar to another widespread nosocomial epi-
demic MRSA strain N315. These results indicate that
some persistent and intermittent carriers carry epidemic
MRSA strains in their nares over variable periods of time.
Discussion
There is considerable evidence indicating that SA car-
riage is an important risk factor for endogenous infec-
tion, and recent studies have substantiated that SA nasal
carriage is multi-factorial, involving both host and bac-
terial factors [7,9,28,49-51]. However, little is known
about the extent to which the colonizing strains’ factors
contribute to persistent versus intermittent carriage of
SA in the human nose. Therefore, as one of our goals,
we set out to investigate whether there is preferential
colonization by particular genotypes of SA strains among
persistent and intermittent carriers. We observed no
preferential colonization by particular genotypes of SA
strains during colonization of either persistent or inter-
mittent carriers. These findings reveal the close genetic
relatedness of SA strains carried by the carriers in our
cohort and raise additional questions about other factors
that are responsible for determining persistent versus
intermittent carriage states. Previous studies suggest that
host factors are crucial determinants of SA carriage
[50,52] and the fact that this study could not find any
genetic differences between strains colonizing persistent
and intermittent carriers, collectively may imply as yet
unknown factors (including host, microbiome and envir-
onment [53]) could primarily be responsible for deter-
mining carriage state.
The definition of persistent carriage varies between
studies, and one study defined persistent carriage based
on a semi-quantitative approach, called the “culture
rule” where nasal swabs were collected one week apart
to determine persistent or intermittent carriage [54].
However, it is arguable that a more comprehensive lon-
gitudinal sampling over longer periods of time is re-
quired to identify true persistent carriers. In the current
study, extensive longitudinal monitoring of healthy indi-
viduals was performed for a period of up to three years
Figure 5 spa and clfB repeat domain lengths are
indistinguishable between persistent and intermittent carriers.
Plots comparing X domain repeat region of spa and R region
lengths of clfB between persistent and intermittent carrier SA strains.
Table 4 Classification of MRSA strains from persistent
and intermittent carriers using SCCmec typing
Donor MLST Sequence
type (ST)
SCCmec
type
D535-2a ST30 I
D535-3-4-5-6-7-8-10-11-12-
13-14-15-16
ST5 IV
D547b ST30 I
D565-1-3 ST87 III
D618 ST30 IV
D795-2 ST15 II
D798-1-2-3-4-5-6 ST8 IV
aBold indicates persistent MRSA carrier strains.
bItalics indicates intermittent MRSA carrier strains.
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to differentiate true persistent carriers from intermittent
carriers and non-carriers. This distinction is crucial be-
cause bacterial loads between persistent and intermittent
carriers vary widely (about 1000 fold more CFUs in per-
sistent carriers [54]), which puts persistent carriers at a
higher risk of acquiring SA infections [11,15]. Interest-
ingly, we observed that some persistent carriers carry
highly virulent epidemic CA-MRSA strains like USA300
in their nares longitudinally over time, potentially put-
ting them at greater risks of acquiring MRSA infections.
CA-MRSA clone USA300 is a widely disseminated viru-
lent strain that is responsible for majority of community
associated soft tissue and skin infections [55,56]. Though
SA nasal carriage itself is seemingly benign to the host’s
nose, carriers in general are known to require the use of
antibiotics more than non-carriers (Rotterdam ERGO
cohort [57]). More frequent antibiotic usage could lead
to the emergence of multidrug resistant SA strains, in
addition to affecting the equilibrium of the host’s com-
mensal flora.
Previous studies have suggested that a single SA strain
often colonizes the nose for long periods of time in per-
sistent carriers while strains colonizing intermittent car-
riers tend to exhibit more genotypic diversity as periods
of decolonization and recolonization occur [9,37]. In
contrast, our longitudinal sampling and genotyping stud-
ies (using MLST, spa and clfB) revealed that SA strains
carried by both persistent and intermittent carriers clus-
tered into the same clades exhibiting high degree of gen-
etic relatedness and SA strains carried in their nares
change over varying periods of time. It is likely, however,
that these changes are due to the acquisition of distinct
strains—that are genetically similar to the one being re-
placed—as opposed to the same strain undergoing muta-
tional events. While high sub-ST strain resolution and
genotypic analyses of relatedness were obtained in this
study, large scale whole genome sequencing of SA
strains isolated from intermittent and persistent carriers
may be the most accurate technique in discerning the
genetic relatedness in these SA strains. Next generation
sequencing technologies could surely assist with such
large-scale genome studies [58].
Several hypervariable virulence genes like spa and clfB
have been postulated to be involved in SA nasal carriage
[7,29,30,32-35,59]. However, it is unclear whether poly-
morphisms in these genes and differences in their repeat
lengths would affect the ability of SA to bind nasal epi-
thelia and hence, contribute to persistent or intermittent
carriage. Our longitudinal analyses revealed that strains
isolated from persistent and intermittent carriers showed
a high degree of genetic relatedness with respect to poly-
morphic changes in spa and clfB genes. These findings
echo the findings of a previous study, which demon-
strated that polymorphisms in repeat regions of virulent
genes spa and coa (coagulase) do not contribute to per-
sistent carriage [60]. In fact, no studies to date have been
able to detect any bacterial factors involved in
distinguishing persistent versus intermittent carriage
states, suggesting a greater role for other factors in car-
riage type.
It has been previously speculated that the carriage
state can be imposed on members of the same house-
hold [61,62]. The current study, though limited, also ob-
served patterns of SA transmission among individuals
living in the same household in which persistent and
intermittent carriers cohabitating in the household har-
bored genetically similar SA strains. In a similar fashion,
studies among the institutionalized elderly population
observed that both persistent and intermittent carriage
strains are shared among household members and the
transmitted SA strains exhibited genotypic similarities
[61]. However, additional correlative studies using a lar-
ger cohort of individuals living in the same household
are necessary.
Bacterial interference has been hypothesized to be in-
volved in determining SA non-carriage state rather than
carriage state. Commensal flora of the body are known
to protect the host against acquisition of new SA strains
[63]. The phenomenon of bacterial interference contrib-
uting to SA nasal colonization was elegantly demon-
strated in a recent study by Iwase and colleagues in
which Staphylococcus epidermidis, a resident bacterium
of the human nares, was shown to inhibit both nasal
colonization and biofilm formation of SA. Specifically,
they demonstrated that a serine protease (Esp) secreting
S. epidermidis eliminated SA colonizing the nasal cavities
of healthy individuals [64]. Perhaps, the absence of Esp-
expressing S. epidermidis in the nasal niche could poten-
tially contribute to persistent SA carriage. Additionally,
competitive bacterial interference between SA and Strepto-
coccus pneumoniae have also been studied extensively.
Several studies have confirmed an inverse relationship be-
tween SA and S. pneumoniae colonization in the nasopha-
ryngeal niche [62,65]. This inverse relationship between
SA and S. pneumoniae could influence SA carriage.
While we have achieved our goal of assessing the
genotypic diversity between SA strains from persistent
and intermittent carriers, we find it pertinent to note
that some inherent limitations complicate data interpret-
ation. This study focused only on nasal carriage strains,
although SA is known to colonize other extra-nasal re-
gions in humans [9]. Regarding the labeling of persistent
and intermittent carriers it is important to note that the
success rate for isolating SA from swab samples never
reaches 100%. Moreover, the sample collection was
dependent largely on the willingness of donors partici-
pating in the study, which lead to gaps in periodicity of
sample collection.
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Conclusion
The current study illustrates the lack of genotypic differ-
ences in SA colonizing persistent and intermittent car-
riers, and the strain relatedness between these carriers
observed within the study may be higher than previously
thought. Assessment of nasal carriage dynamics between
strains colonizing persistent and intermittent carriers
and understanding complex host-pathogen interactions
during carriage are crucial for developing effective inter-
vention strategies for nasal carriage and subsequent
prevention of community-associated and nosocomial SA
infections.
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